skip to main content


Evgen has licensed its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence Ltd.

Juvenescence will deploy the Sulforadex® stabilisation technology to manufacture and market a nutritional health product containing a defined and stable dose of sulforaphane, derived from natural sources. Launch is expected within next two years.